Development and testing of performance measures for pharmacy services

Johnson, 1995, Drug-related morbidity and mortality, Arch Intern Med, 155, 1949, 10.1001/archinte.1995.00430180043006 Johnson, 1997, Drug-related morbidity and mortality and the economic impact of pharmaceutical care, Am J Health Syst Pharm, 54, 554, 10.1093/ajhp/54.5.554 Scholle, 2009, Availability of data for measuring physician quality performance, Am J Manag Care, 15, 67 Scholle, 2008, Benchmarking physician performance: reliability of individual and composite measures, Am J Manag Care, 14, 829 Chernew, 2008, Impact of decreasing copayments on medication adherence in a disease-management environment, Health Aff, 27, 103, 10.1377/hlthaff.27.1.103 Nau, 2007, Adherence analysis using a visual analog scale versus claims-based estimation, Ann Pharmacother, 41, 1792, 10.1345/aph.1K264 Rozenfeld, 2008, Oral antidiabetic medication adherence and glycemic control in managed care, Am J Manag Care, 14, 71 Hepler, 2003 Angaran, 1991, Selecting, developing, and evaluating indicators, Am J Hosp Pharm, 48, 1931 Isetts, 2003, Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals, Arch Intern Med, 163, 1813, 10.1001/archinte.163.15.1813 Farris, 1993, Assessing the quality of pharmaceutical care. II. Application of concepts of quality assessment from medical care, Ann Pharmacother, 27, 215, 10.1177/106002809302700218 Fry, 2004, Framework for pharmacy services quality improvement—a bridge to cross the quality chasm. Part I. The opportunity and the tool, J Manag Care Pharm, 10, 60